Skip to main content
. 2022 Jan 7;40(5):449–458. doi: 10.1200/JCO.21.01918

FIG 1.

FIG 1.

Association of baseline variables with palbociclib discontinuation and dose reduction to 100 mg. Individual forest plots can be found in the Data Supplement. AI, aromatase inhibitor: ECOG, Eastern Cooperative Oncology Group; ET, endocrine therapy; G, grade; HR, hazard ratio; PgR, progesterone receptor; Tis, carcinoma in situ; Tx, primary tumor cannot be assessed.